This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.
Company Filing History:
1 out of 834,350 Years Active: 2000
Title: The Innovations of Detley Behnke
Introduction
Detley Behnke is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. His work has implications for medical applications, showcasing the intersection of science and innovation.
Latest Patents
Detley Behnke holds a patent for the invention titled "Expression of signal-peptide-free staphylokinases." This invention relates to recombinant staphylokinase polypeptides that exhibit a plasminogen activator effect. The polypeptides are produced by expressing DNA sequences that are devoid of signal-peptide-coding regions. This innovation has the potential to enhance therapeutic strategies in treating various medical conditions.
Career Highlights
Throughout his career, Detley Behnke has focused on advancing the understanding and application of recombinant proteins. His dedication to research and development has led to breakthroughs that contribute to the field of biotechnology. His patent reflects his commitment to innovation and the pursuit of scientific excellence.
Collaborations
Detley Behnke has collaborated with esteemed colleagues, including Bernhard Schlott and Karl-Heinz Guhrs. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Detley Behnke's contributions to biotechnology through his innovative patent demonstrate the importance of research and collaboration in advancing medical science. His work continues to inspire future innovations in the field.